Carotid IMT and Ultrafast PWV as Predictors of CV Events and Mortality in Hemodialysis Patients

Background and study objective

Arterial remodeling is a common feature of end-stage renal disease (ESRD) and contributes to high cardiovascular (CV) risk in patients on maintenance hemodialysis (MHD). This prospective cohort study assessed whether structural and local biomechanical carotid measures — specifically carotid intima-media thickness (CIMT) and ultrafast pulse wave velocity (ufPWV) parameters (PWV-BS and PWV-ES) — predict CV events and all-cause mortality in MHD patients, and whether diabetes modifies these relationships.

Study design and population

The study enrolled 115 maintenance hemodialysis patients who were followed prospectively for 39 months. Non-ESRD control data were used for comparison of vascular measures. The report provides cohort size, follow-up duration, and event counts but does not detail inclusion/exclusion criteria, dialysis vintage, or baseline medical therapy in the abstract.

Imaging and vascular measurements

Two carotid-based measures were analyzed: CIMT, quantified in millimeters, and ultrafast pulse wave velocity (ufPWV) measured at the beginning of systole (PWV-BS) and the end of systole (PWV-ES). The study compared CIMT and ufPWV parameters between MHD patients and non-ESRD controls and evaluated their associations with subsequent clinical events.

Clinical outcomes and follow-up

During a median or fixed follow-up of 39 months, the cohort experienced 21 cardiovascular events and 17 deaths (all-cause mortality). The abstract reports these event counts but does not provide detailed event definitions or adjudication procedures in the presented text.

Primary and subgroup results

Compared with non-ESRD controls, MHD patients had significantly higher CIMT (1.60 vs 0.80 mm, p = 0.004). In contrast, ufPWV parameters (PWV-BS and PWV-ES) appeared comparable between MHD patients and controls in the measures reported.

In univariable analysis within the MHD cohort, CIMT was associated with cardiovascular events and showed a positive correlation with diabetes (r = 0.271, p = 0.003). After adjusting for diabetes, the association between CIMT and cardiovascular events was no longer statistically significant (hazard ratio [HR] 1.350, 95% confidence interval [CI] 0.865–2.106, p = 0.186).

Neither PWV-BS nor PWV-ES were associated with cardiovascular events or all-cause mortality in the analyses performed within the overall MHD population.

A preliminary subgroup analysis among patients with diabetes (n = 36, in whom 15 CV events occurred) identified an inverse association between the left carotid PWV-ES and CV events. The authors characterize this isolated subgroup finding as hypothesis-generating and in need of independent validation.

Statistical adjustments and key associations

The abstract reports univariable and limited multivariable results, highlighting that the apparent univariable association of CIMT with CV events was attenuated and lost statistical significance after adjustment for diabetes. Exact covariates included in multivariable models beyond diabetes are not specified in the abstract. The text provides one adjusted HR for CIMT (HR 1.350, 95% CI 0.865–2.106, p = 0.186).

Interpretation and clinical implications

Key interpretive points from the study are:

• CIMT is greater in patients on MHD compared with non-ESRD controls, consistent with accelerated carotid structural remodeling in ESRD.
• The association between CIMT and CV events appears to be confounded or mediated by diabetes, since adjustment for diabetes removed the statistical association in the limited model presented.
• Local carotid ufPWV parameters (PWV-BS and PWV-ES) did not predict CV events or all-cause mortality in the overall hemodialysis cohort in this study.
• A single, unexpected finding in the diabetic subgroup (inverse association of left PWV-ES with CV events) is reported but should be treated as exploratory.

Clinically, these results suggest that while CIMT is elevated in MHD patients, its independent prognostic value for CV events may be limited once diabetes is accounted for. ufPWV did not provide additional prognostic information in this sample.

Limitations and need for validation

The authors explicitly note limitations that affect interpretation:

• Small sample size (115 MHD patients) and limited numbers of events (21 CV events, 17 deaths) reduce statistical power.
• Multiple comparisons increase the risk that isolated subgroup findings represent chance associations.
• The abstract does not report detailed covariate adjustment sets, methodologic specifics (e.g., imaging protocol reproducibility, blinding, event adjudication), or baseline patient characteristics beyond diabetes correlation, limiting assessment of residual confounding.

Consequently, the isolated association observed between left PWV-ES and CV events in the diabetic subgroup is considered hypothesis-generating and requires independent validation in larger cohorts.

Conclusions

In this prospective cohort of 115 MHD patients followed for 39 months, CIMT was higher than in non-ESRD controls but its association with cardiovascular events was not independent of diabetes in the models reported. Local ufPWV measures (PWV-BS and PWV-ES) were not associated with CV events or all-cause mortality in the overall hemodialysis population. A subgroup observation linking left PWV-ES and CV events among patients with diabetes is exploratory and should be validated in larger studies.

Implications for research and practice

Further research with larger, well-powered cohorts and prespecified multivariable models is needed to determine whether CIMT or local ufPWV provide independent prognostic information beyond established clinical risk factors such as diabetes in patients on hemodialysis. The abstract does not provide practice-change recommendations; instead it highlights areas for validation and additional study.